Syndax Pharmaceuticals, Inc. (SNDX)
18.19
-0.63
(-3.35%)
USD |
NASDAQ |
Sep 11, 16:00
18.19
0.00 (0.00%)
After-Hours: 17:27
Syndax Pharmaceuticals Gross Profit (TTM) : 241.59M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 241.59M |
| March 31, 2026 | 208.69M |
| December 31, 2025 | 165.62M |
| September 30, 2025 | 106.46M |
| June 30, 2025 | 75.19M |
| March 31, 2025 | 38.51M |
| December 31, 2024 | 19.35M |
| September 30, 2024 | 12.49M |
| June 30, 2024 | -0.009M |
| March 31, 2024 | -0.161M |
| December 31, 2023 | -0.271M |
| September 30, 2023 | -0.383M |
| June 30, 2023 | -0.488M |
| March 31, 2023 | -0.446M |
| December 31, 2022 | -0.454M |
| September 30, 2022 | 126.12M |
| June 30, 2022 | 126.22M |
| March 31, 2022 | 126.33M |
| December 31, 2021 | 126.46M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | -0.004M |
| June 30, 2016 | -0.004M |
| March 31, 2016 | -0.008M |
| September 30, 2014 | -0.012M |
| June 30, 2014 | -0.008M |
| March 31, 2014 | -0.014M |
| December 31, 2013 | -0.01M |
| September 30, 2013 | -0.006M |
| March 31, 2013 | -0.006M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Viking Therapeutics, Inc. | -0.45M |
| Kura Oncology, Inc. | 75.37M |
| ACADIA Pharmaceuticals, Inc. | 1.038B |
| Alnylam Pharmaceuticals, Inc. | 3.827B |
| Anika Therapeutics, Inc. | 75.00M |